Press Releases

November 1, 2010 Lupin Net Profit up by 34 % in Q2, FY 2010-11 Robust Growth, Strong Profits

October 14, 2010 Lupin announces settlement with Warner Chilcott of Loestrin® 24 Fe and Femcon® Fe Patent Litigations

October 4, 2010 Lupin Announces Final FDA Approval of Generic Hyzaar® and Cozaar®

August 3, 2010 Lupin appoints Paul McGarty as President for Lupin Pharmaceuticals Inc.

July 28, 2010 Lupin Net Profit up by 40 % in Q1, FY 2010-11 Consistent Growth, Strong Profits

July 1, 2010 Lupin receives FDA approval for Famotidine for Oral Suspension

June 4, 2010 Lupin receives FDA approval for Lamotrigine tablets

May 5, 2010 Lupin FY 2009-10 Consolidated Net Profits up 36% to Rs 6816 mn

April 20, 2010 Lupin receives FDA approval for Imipramine Pamoate Capsules